NFKB1 and amyotrophic lateral sclerosis: Increased microglial activation of NF-κB (by EMSA and phospho-p65 immunoblot) in spinal cord of both human patients with ALS and in the SOD1-G93A mouse model of ALS has been shown to parallel disease progression (108).